Overview
- 3 inspections across 2 sites are on record.
- 1 Form 483 observation is attributed to this investigator.
- Most recent recorded activity is 2025-04-28.
At a glance
Inspections
3
Sites
2
Observations
1
Career since
Mar 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Catalent Maryland Inc | 28 Apr 2025 | Biologics | On file |
| Sarepta Therapeutics Inc | 24 Mar 2023 | Biologics | View 483 → |
| Catalent Maryland Inc | 10 Mar 2023 | Biologics | On file |
Sites inspected
Catalent Maryland IncHarmans, United States2 insp.
Sarepta Therapeutics IncAndover, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Emmanuel Adu-Gyamfi2 shared
Sarah E Underwood1 shared
Ou Ma1 shared
Alifiya H Ghadiali1 shared
Kevin J Matthews1 shared
Grace I Cortesini1 shared
Viviana R Ramirez1 shared
Scott T Ballard1 shared
Full investigator report
Get the verbatim findings behind Sukyoung Sohn's 1 observation
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site